USP8 is a Novel Therapeutic Target in Melanoma Through Regulating Receptor Tyrosine Kinase Levels

Baoxue Duan1 Department of Dermatology, Xiangyang No.1 People’s Hospital, Hubei University of Medicine, Xiangyang, Hubei, People’s Republic of China

Changying Wang2 Department of Oncology, Xiangyang No.1 People’s Hospital, Hubei University of Medicine, Xiangyang, Hubei, People’s Republic of China

Zeng Liu3 Department of Oncology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, People’s Republic of ChinaCorrespondence[email protected] [email protected]

https://orcid.org/0000-0003-2098-3297

Xiaoyu Yang2 Department of Oncology, Xiangyang No.1 People’s Hospital, Hubei University of Medicine, Xiangyang, Hubei, People’s Republic of China

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Jianing Tang, Guo Long, Kuan Hu, Desheng Xiao, Shuang Liu, Liang Xiao, Ledu Zhou & Yongguang Tao. (2023) Targeting USP8 Inhibits O‐GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT. Advanced Science 10:33.
Crossref

Beibei Sha, Yaxin Sun, Shan Zhao, Miaomiao Li, Wenjing Huang, Zheng Li, Jianxiang Shi, Xuefei Han, Pei Li, Tao Hu & Ping Chen. (2022) USP8 inhibitor–induced DNA damage activates cell cycle arrest, apoptosis, and autophagy in esophageal squamous cell carcinoma. Cell Biology and Toxicology 39:5, pages 2011-2032.
Crossref

Jianing Tang, Guo Long, Liang Xiao & Ledu Zhou. (2023) USP8 positively regulates hepatocellular carcinoma tumorigenesis and confers ferroptosis resistance through β-catenin stabilization. Cell Death & Disease 14:6.
Crossref

Yu Long, Zengchun Hu, Dian Yang, Fuqiang Wang, Chen’ge Zhao, Yang Zhang, Yingqiu Zhang, Hui Ma & Huiyi Lv. (2023) Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth. Open Life Sciences 18:1.
Crossref

Lucia Janacova, Michaela Stenckova, Petr Lapcik, Sarka Hrachovinova, Pavla Bouchalova, David Potesil, Roman Hrstka, Petr Müller & Pavel Bouchal. (2023) Catechol-O-methyl transferase suppresses cell invasion and interplays with MET signaling in estrogen dependent breast cancer. Scientific Reports 13:1.
Crossref

Yucheng Tian, Kang Liu, Ruoyi Liu, Zhixia Qiu, Yifan Xu, Wei Wei, Xi Xu, Jubo Wang, Hong Ding, Zhiyu Li & Jinlei Bian. (2022) Discovery of Potent Small-Molecule USP8 Inhibitors for the Treatment of Breast Cancer through Regulating ERα Expression. Journal of Medicinal Chemistry 65:13, pages 8914-8932.
Crossref

Anais Prouteau, Stephanie Mottier, Aline Primot, Edouard Cadieu, Laura Bachelot, Nadine Botherel, Florian Cabillic, Armel Houel, Laurence Cornevin, Camille Kergal, Sébastien Corre, Jérôme Abadie, Christophe Hitte, David Gilot, Kerstin Lindblad-Toh, Catherine André, Thomas Derrien & Benoit Hedan. (2022) Canine Oral Melanoma Genomic and Transcriptomic Study Defines Two Molecular Subgroups with Different Therapeutical Targets. Cancers 14:2, pages 276.
Crossref

USP8 is a Novel Therapeutic Target in Melanoma Through Regulating Receptor Tyrosine Kinase Levels

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

USP8 is a Novel Therapeutic Target in Melanoma Through Regulating Receptor Tyrosine Kinase Levels

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date